Resalis Therapeutics

Torino, Italy

Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche

Oct 2024

Corporate Round

Biotechnology Clinical Trials Health Care Medical Pharmaceutical

Top Investors

SanofiClaris VenturesSunstone Life Science VenturesItalian Angels for GrowthClub degli Investitori

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Resalis Therapeutics

Who are Resalis Therapeutics's investors?

Resalis Therapeutics's investors include Sanofi, Claris Ventures, Sunstone Life Science Ventures, Italian Angels for Growth, Club degli Investitori.

Where is Resalis Therapeutics headquartered?

Resalis Therapeutics is headquartered in Torino, Italy.

What does Resalis Therapeutics do?

Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche

What stage is Resalis Therapeutics at?

Resalis Therapeutics is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 28, 2024.

MLA

"Resalis Therapeutics — Funding & Investors." VCBacked, October 28, 2024, https://www.vcbacked.co/company/resalis-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Resalis Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/resalis-therapeutics

Wikipedia (cite web)

{{cite web |title=Resalis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/resalis-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 28, 2024.